ArticleBMC infectious diseases2025
Clustering and modeling joint-trajectories of HIV/AIDS and tuberculosis mortality rates using bayesian multi-process latent growth model: A global study from 1990 to 2021.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The application of machine learning in clinical microbiology and infectious diseases.Frontiers in cellular and infection microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe bidirectional association of HIV/AIDS and Tuberculosis (TB) presents significant global health challenges. However, the relationship between these dual epidemics and the heterogeneity in their mortality rate patterns have not been properly addressed. Therefore, the aim of this study was to cluster and model the joint trajectories of HIV/AIDS and TB mortality rates from 1990 to 2021 worldwide.
methodsIn this longitudinal study, the HIV/AIDS and TB mortality rates data for 204 countries from 1990 to 2021 were obtained from the global burden of disease database. The longitudinal k-means clustering approach was utilized to categorize countries into homogeneous subgroups based on the joint patterns of HIV/AIDS and TB mortality rates. Subsequently, the Bayesian multi-process nonlinear Latent Growth Model (LGM) was conducted to concurrently estimate the patterns of HIV/AIDS and TB mortality rates.
resultsThe average global TB mortality rates dropped from 30.61 to 13.34 per 100,000 between 1990 and 2021. Meanwhile, the average HIV/AIDS mortality rates rose from 10.94 to 48.42 per 100,000 by 2000 before declining to 16.90 per 100,000 in 2021. The Bayesian multi-process nonlinear LGM indicated that the intercepts for the overall HIV/AIDS and TB models were 11.168 and 30.184, and the slopes were 16.104 and - 1.040, respectively. This suggests that the initial HIV/AIDS and TB mortality rates were 11.168 and 30.184 persons per 100,000, and the rates of change were 16.104 and - 1.040 persons per 100,000 every five years. However, the strength and direction of the rate of change were dependent on the factor loading scores, as they exhibited a nonlinear trend. Finally, the 204 countries were clustered into three distinct subgroups, each with different intercepts and slopes. Cluster A demonstrated the lowest HIV/AIDS and TB mortality rates throughout the study, while Cluster C exhibited the highest mortality rates.
conclusionsAlthough the overall global HIV/AIDS and TB mortality rates have declined, Southern African countries continue to bear a significant burden of HIV/AIDS and TB, with no significant reduction observed in TB mortality rates from 1990 to 2021. Therefore, prioritizing these countries is crucial to achieving the Sustainable Development Goals (SDGs) of eradicating the global HIV/AIDS and TB epidemics by 2030 and 2035, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.